Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | CDK2 | P24941 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5-Nitro-2-Phenylpropylaminobenzoic Acid [Nppb] SCHEMBL29375101 | 1.00 | MAPT (1.00) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL4217741 | 0.96 | MAPT (0.93) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL3029764 | 0.92 | MAPT (1.00) | MAPTCDK2KMT2AMEN1NPC1 | |
| 5-Nitro-2-Phenylpropylaminobenzoic Acid [Nppb] SCHEMBL7821604 | 0.90 | MAPT (0.82) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL6374917 | 0.90 | MAPT (0.82) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL14280729 | 0.87 | CDK2 (0.77) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL4212246 | 0.84 | MAPT (1.00) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL3843127 | 0.82 | KMT2A (0.71) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL27577353 | 0.82 | MAPT (0.69) | MAPTCDK2KMT2AMEN1NPC1 | |
| SCHEMBL4198828 | 0.81 | MAPT (0.80) | MAPTCDK2KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2186 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744663-A2 | SKIN COMPOSITION | Eaderm Co., Ltd. (JP) | 2026-05-20 | — | — | EP | claimed |
| US-20260112450-A1 | METHODS FOR SELECTION OF CANCER PATIENTS FOR ANTI-ANGIOGENIC AND IMMUNE CHECKPOINT BLOCKAGE THERAPIES AND COMBINATIONS THEREOF | WASHINGTON UNIVERSITY ST LOUIS (US) | 2026-04-23 | — | — | US | claimed |
| US-20260016488-A1 | CIRCULATING PROTEIN BIOMARKERS OF NECROTIZING ENTERROCOLITIS | UNIV COLORADO REGENTS (US) | 2026-01-15 | — | — | US | claimed |
| US-20250345381-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING CARDIOVASCULAR AND KIDNEY DISEASES AND METHOD FOR PREPARING SAME | BEIJING CAPITALBIO PHARMA CO LTD (CN) | 2025-11-13 | — | — | US | claimed |
| US-12447096-B1 | Massage roller | Guangdong Transcontinental Technology Co., Ltd. (CN) | 2025-10-21 | — | — | US | claimed |
| US-20250320458-A1 | CARDIOMYOCYTE SUBTYPES AND METHODS OF MAKING AND USING | UNIV HEALTH NETWORK (CA) | 2025-10-16 | — | — | US | claimed |
| US-20250312336-A1 | Compositions And Methods For Treating Cancer With Calcium Channel Inhibitors | INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER (US) | 2025-10-09 | — | — | US | claimed |
| US-20250297321-A1 | METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM | INST NAT SANTE RECH MED (FR) | 2025-09-25 | — | — | US | claimed |
| US-20250161330-A1 | METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS | REMEDY PHARMACEUTICALS, INC. (US) | 2025-05-22 | — | — | US | claimed |
| US-20250140828-A1 | METHOD OF PROCESSING POSITIVE ELECTRODE ACTIVE MATERIAL PARTICLES, AND POSITIVE ELECTRODE ACTIVE MATERIAL AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | BASF TODA BATTERY MATERIALS, LLC (JP) | 2025-05-01 | — | — | US | claimed |
| EP-1284729-A1 | A(BETA)42 LOWERING AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2003-02-26 | — | — | EP | claimed |
| US-20020128319-A1 | Abeta 42 lowering agents | MYREXIS, INC. | 2002-09-12 | — | — | US | claimed |
| US-20020065325-A1 | Use of CLC3 chloride channel blockers to modulate vascular tone | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2002-05-30 | — | — | US | claimed |
| WO-2001078721-A1 | Aβ42 LOWERING AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2001-10-25 | — | — | WO | claimed |
| US-6187756-B1 | Composition and methods for treatment of neurological disorders and neurodegenerative diseases | THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-02-13 | — | — | US | claimed |
| EP-0713904-B1 | Process for treating titanium dioxide pigments, titanium dioxide pigment and its use in papermaking | MILLENNIUM INORGANIC CHEM (FR) | 2000-07-26 | — | — | EP | claimed |
| US-5705530-A | SIDE EFFECT REDUCTION; GLAUCOMA TREATMENT | ALLERGAN (US) | 1998-01-06 | — | — | US | claimed |
| EP-0786994-A2 | USE OF CHLORIDE CHANNEL BLOCKERS FOR REDUCING INTRAOCULAR PRESSURE | Allergan (US) | 1997-08-06 | — | — | EP | claimed |
| US-5559151-A | Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers | ALLERGAN (US) | 1996-09-24 | — | — | US | claimed |
| WO-1996016647-A2 | USE OF CHLORIDE CHANNEL BLOCKERS FOR REDUCING INTRAOCULAR PRESSURE | ALLERGAN (US) | 1996-06-06 | — | — | WO | claimed |